Cardinal Health Q2 revenue $65.6B (+19%), non-GAAP EPS $2.63 (+36%), raises FY26 EPS outlook to $10.15-$10.35

CARDINAL HEALTH INC

Revenue $65.6B (+19% YoY); GAAP diluted EPS $1.97 (+19%); non-GAAP diluted EPS $2.63 (+36%).
Pharma & Specialty profit $687M (+29%); Global Medical Products profit $37M (+106%); Other profit $179M (+52%).
FY2026 non-GAAP EPS guidance raised to $10.15-$10.35, representing 23%-26% growth.
Year-to-date share repurchases of $750M completed; reached targeted leverage range.
Acquired Solaris Health (urology MSO, >750 providers) on Nov 3; introduced ContinuCare Pathway program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.